(redirected from ribonucleic acid)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to ribonucleic acid: deoxyribonucleic acid, ATP
References in periodicals archive ?
Pharmaceutical Industry: Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
Keywords in this release: ribonucleic acid interference, RNAi, siRNA, shRNA, miRNA, World, in-vitro delivery, transfection reagents, in-vivo delivery, HeLa cells, polymerase chain reaction, PCR, messenger RNA, mRNA, gene-silencing technique, post-transcriptional function, protein knockdown, phenotypic alteration, functional genomics, western blot kits, research, information, market, trends, technology, service, forecast, market share
CytRx Corporation is a biopharmaceutical research and development company engaged in the development of products, primarily in the area of small molecules and ribonucleic acid interference (RNAi).
formerly known as Neos Discovery) to commercialize technology that identifies drug compounds that interrupt the lifecycle of pathogens through a novel mechanism of action - the inhibition of transfer ribonucleic acid (tRNA).
6 /PRNewswire-FirstCall/ -- CytRx Corporation , a biopharmaceutical company engaged in the development and commercialization of human therapeutics primarily in the area of small molecules and ribonucleic acid interference (RNAi), today announced that it has received written notice from the Nasdaq Stock Market granting it an additional 180 calendar day compliance period, or until June 2, 2006, to regain compliance with the Nasdaq Capital Market's $1.
The instrument is a ring formed by six identical strands of ribonucleic acid, or RNA, the two groups report independently in the July Molecular Cell.
a premium provider of innovative products for the study and analysis of ribonucleic acid (RNA), the central molecule used in gene expression and regulation.
G00101 represents a first-in-class approach to fight influenza and is one of the most advanced anti-influenza compounds based on the recently discovered cellular mechanism known as small interfering ribonucleic acid (siRNA).
Many researchers in the field have turned to ribonucleic acid (RNA).
A complex enzyme composed of several proteins and a strand of ribonucleic acid (RNA), telomerase affixes brief DNA sequences to the ends of chromosomes.
Kriegsman, president and CEO of CytRx Corporation, can share his expertise on Ribonucleic Acid Interference (RNAi).
They revealed that a fragment of ribonucleic acid (RNA), once thought to be no more than a by-product, plays a crucial role in regulating inflammation and the development of Alzheimer's disease.